Clinical News
Informatics
Industry News
Medical, Legal, And Practice
Education
Subspecialties
More
Sign In
CT
Digital X-Ray
Interventional
Molecular Imaging
MRI
Radiation Oncology/Therapy
Ultrasound
Womens Imaging
Molecular Imaging: Page 16
Researchers scan first patient in study using MedTrace PET tracer
By
AuntMinnieEurope.com staff writers
Osaka University Hospital in Japan has scanned the first patient with MedTrace's PET tracer system.
May 3, 2023
AuntMinnieEurope.com Molecular Imaging Insider
By
Erik L. Ridley
May 2, 2023
Curasight joins forces with Curium
By
AuntMinnieEurope.com staff writers
Danish theranostics technology developer Curasight has formed a global partnership with nuclear medicine firm Curium to support the development of its uTrace radiopharmaceutical for use in prostate cancer.
May 2, 2023
Combining PET/CT and MRI can predict outcome in cervical cancer
By
Philip Ward
The combination of PET/CT and MRI response assessment after chemoradiotherapy in cases of locally advanced cervical carcinoma (LACC) is a more accurate predictor of patient outcome than either modality alone, U.K. researchers have reported in a new award-winning study.
May 2, 2023
GE HealthCare posts revenue gains in Q1
By
AuntMinnieEurope.com staff writers
GE HealthCare produced double-digit percentage organic growth in first-quarter revenue, as well as adjusted earnings before interest and taxes and earnings per share.
April 27, 2023
Telix acquires Vienna's Dedicaid for over 1 million euros
By
AuntMinnieEurope.com staff writers
Telix Pharmaceuticals has acquired Vienna, Austria-based Dedicaid, a spin-off of the Medical University Vienna, for $1.2Â million (1.1 million euros).
April 27, 2023
Emerging PET tracer for prostate cancer displays promise
By
Will Morton
PET/CT imaging with F-18 PSMA-1007 detects significantly more prostate cancer than imaging using the standard F-18 fluorocholine radiotracer, according to clinical trial results published in the April issue of the
Journal of Nuclear Medicine
.
April 27, 2023
On your bike: A day in the life of Paul McCoubrie
By
Dr. Paul McCoubrie
Ranting about the iniquities of clinicians and laboriously detailing your burnout helps no one, writes Dr. Paul McCoubrie in a new column. He's a passionate believer in decent coffee, black pudding for breakfast, cycling to work, and being a good colleague.
April 24, 2023
German team elaborates on how to reduce PET/MRI scan times
By
Will Morton
PET/MRI breast cancer imaging time can be cut in half without losing key diagnostic information, and this could increase the use of the modality for this indication and streamline patient throughput, investigators from the University of Dusseldorf have found.
April 20, 2023
PET/CT proves superior in detecting invasive breast cancer
By
Will Morton
PET/CT imaging surpasses bone scintigraphy for detecting bone metastases in women with invasive breast cancer and should be the technique of choice to stage these patients, according to a team of investigators from Portugal.
April 16, 2023
Danish team uses PET/CT to predict outcome in metastatic breast cancer
By
Will Morton
F-18 FDG-PET/CT imaging appears to be a better predictor of survival than contrast-enhanced CT for monitoring patients with metastatic breast cancer, according to investigators from Odense University in Denmark.
April 10, 2023
Ablaze announces progress on liver cancer therapy
By
AuntMinnieEurope.com staff writers
Ablaze Pharmaceuticals has licensed a peptide drug candidate from RayzeBio that it will develop to target the liver cancer biomarker GPC3. The plans is to market the new drug in China, where the company is headquartered.
April 2, 2023
Previous Page
Page 16 of 121
Next Page
